Skip to main content
Top

Open Access 28-02-2024 | Metastasis | Editorial

Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis

Authors: Stanley P. Leong, S. David Nathanson, Jonathan S. Zager

Published in: Clinical & Experimental Metastasis

Login to get access

Excerpt

The International Congress on Cancer Metastasis through the Lymphovascular System was first held in 2005, with numerous publications summarizing these biennial meetings. In 2022, we summarized these significant findings in our recently published book on Cancer Metastasis through the Lymphovascular System [1]. Cancer heterogeneity due to mutation [2, 3] and epigenetic changes [4] with association of formation of neoantigens [5, 6] is well known. Cancer progression relating to the cancer microenvironment and the mechanisms of cancer metastasis are under intense study. The 9th International Congress on Cancer Metastasis through the Lymphovascular System, being held between May 4–6, 2019, in San Francisco (www.​cancermetastasis​.​org), addressed the molecular mechanisms of cancer metastasis from the cancer microenvironment to the sentinel lymph nodes in the majority of the cases, then to systemic sites in 20 review articles and 1 commentary. …
Literature
1.
go back to reference Leong SP, Nathanson SD, Zager JS (eds) (2022) Cancer Metastasis Through the Lymphovascular System, Springer Nature Leong SP, Nathanson SD, Zager JS (eds) (2022) Cancer Metastasis Through the Lymphovascular System, Springer Nature
7.
go back to reference Special Issue (by invitation only) : Cancer Metastasis through the Lymphovascular System: Molecular Mechanisms of Cancer Metastasis (2023). Clin Exp Metastasis Special Issue (by invitation only) : Cancer Metastasis through the Lymphovascular System: Molecular Mechanisms of Cancer Metastasis (2023). Clin Exp Metastasis
Metadata
Title
Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis
Authors
Stanley P. Leong
S. David Nathanson
Jonathan S. Zager
Publication date
28-02-2024
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-024-10272-8
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine